课题基金 / 基金详情

项目摘要

项目成果

A ZOLKIEWSKA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Mono-ADP-ribosylation is a posttranslational modification of proteins which is involved in the action of bacterial toxins and in the regulation of cellular processes. Arginine-, cysteine- and aparagine-specific ADP- ribosyltransferases have been identified in animal tissues. NAD:arginine ADP-ribosyltransferase and ADP-ribosylarginine hydrolases, which catalyze the forward and reverse arms of a putative ADP-ribosylation cycle, have been identified in mammalian tissues. ADP-ribosylarginine hydrolase was purified from turkey erythrocytes and rat brain and its CDNA was cloned from the latter tissue. In the case of the arginine-specific ADP- ribosyltransferase, partial purification from rabbit skeletal muscle membranes was reported. To define the structure of this enzyme, it was purified, microsequenced, and cloned. Rabbit skeletal muscle arginine-specific ADP-ribosyltransferase was purified about 215,000-fold by sequential five-step chromatography. On the basis of the amino acid sequences of HPLC-purified tryptic peptides, degenerate oligonucleotide primers were synthesized and used in a polymerase chain reaction (PCR)-based procedure to generate CDNA. A specific probe, based on PCR-generated sequence, was used to screen a rabbit skeletal muscle library. A composite sequence, obtained from library screening and rapid amplification of the 5' end of the CDNA, contained a 981-base-pair open reading frame, encoding a 36,134-Da protein. Escherichia coli cells transformed with an expression vector containing transferase-specific sequence expressed transferase activity. A transferase-specific oligonucleotide probe recognized a 4-kilobase MRNA expressed primarily in rabbit skeletal and cardiac muscle. There was no extended similarity in deduced amino acid sequences of the muscle transferase and several ADP-ribosylating bacterial toxins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADP-RIBOSYLATION CYCLES
ADP-RIBOSYLATION CYCLES
国内基金
海外基金
asr基因调控酸诱导的Escherichia coli O157:H7形成VBNC状态的机制研究
  • 批准号:
    32302245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30.00万元
  • 批准年份:
    2023
  • 负责人:
    潘寒姁
  • 依托单位:
小肠中Escherichia coli分泌细菌毒素诱导肠屏障损伤及细菌易位在炎症性肠病中的机制研究
  • 批准号:
    82371775
  • 项目类别:
    面上项目
  • 资助金额:
    46万元
  • 批准年份:
    2023
  • 负责人:
    朱慧媛
  • 依托单位:
基于Escherichia coli O157:H7亚致死态细胞探究超高压与原儿茶酸协同杀菌机制
  • 批准号:
    31871817
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2018
  • 负责人:
    孙爱东
  • 依托单位:
肠肝轴:从临床患者分离的肠道致病菌株Escherichia coli NF73-1对非酒精性脂肪性肝病的作用及机制研究
  • 批准号:
    81873549
  • 项目类别:
    面上项目
  • 资助金额:
    57.0万元
  • 批准年份:
    2018
  • 负责人:
    刘玉兰
  • 依托单位: